General Information
Version
7.2
Revision date
2023-05-05
Product name
Betamethasone
CAS No.
378-44-9
REACH No
A
Emergency telephone
+1-703-527-3887
Icons in SDS
Company Information
company name
MilliporeSigma Canada Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360FD, H373
Hazard statements
Code
Statements
H360FD
May damage fertility; May damage the unborn child
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H360FD May damage fertility. May damage the unborn child. H373 May cause damage to organs (Liver, Kidney, Endocrine system) through prolonged or repeated exposure. H360FD May damage fertility. May damage the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Reproductive toxicity (Category 1B), H360FD Specific target organ toxicity - repeated exposure (Category 2), Liver, Kidney, Endocrine system, H373 For the full text of the H-Statements mentioned in this Section, see Section 16.